Quotient is an early phase drug development services provider founded in 1990 with purpose-built facilities in Nottingham, UK. Quotient’s proprietary and unique Translational Pharmaceutics® platform integrates clinical testing with formulation development and real-time GMP manufacturing. Over 100 leading pharmaceutical and biotech companies have chosen Translational Pharmaceutics to accelerate the development of their products.
As part of a global expansion strategy, Quotient has acquired three businesses with complementary service portfolios. QS Pharma, SeaView Research and Co-Formulate all reside within the Quotient group, increasing the scale of the Quotient business to approximately 600 employees across 5 sites and with more than 150 clients. The combined businesses remain focused on continuing to deliver drug development solutions that save our customers both time and money.
QS Pharma is a contract development and manufacturing organisation (CDMO), located near Philadelphia, PA, US. QS Pharma has a broad range of formulation development and product manufacturing capabilities, and is capable of supporting customer programs through all stages of development and commercialisation. The business was founded in 2002 and has a strong base of pharmaceutical and biotech customers worldwide. Specialisation is focused around small molecules, with a strong capability to work with high potency molecules.
SeaView is a Phase 1 clinical research business, based in Miami and Jacksonville, FL, US. The business was founded in 1995 and has completed over 500 early phase clinical studies for a range of pharmaceutical and biotech customers. The two facilities have a combined bed capacity of 320 and are capable of undertaking complex clinical research studies including first-in-human investigations, Drug-Drug Interaction, Food Effect/Bioequivalence, and Biosimilar studies.
Co-Formulate Limited was established in September 2007 and provides a comprehensive range of formulation development, analytical and regulatory services to clients in the pharmaceutical, consumer healthcare and personal care industries. The team of scientists, ways of working and state of the art facilities, located at MediCity, enables the business to undertake development activity across all major dosage formats.